@FiercePharma: NIH steps in with $9M Vanderbilt grant after rough season for flu vaccines. More | Follow @FiercePharma
@EricPFierce: ICYMI: #FDA blesses Baxter #saline plant in Spain for shipments to U.S. of 0.9% sodium chloride. Article | Follow @EricPFierce
@CarlyHFierce: Novo, Baxter spar over hemophilia patent amid ITC probe. Story | Follow @CarlyHFierce
> Add "potential antidepressant" to Botox's list of uses; the Allergan injection, best known as a cosmetic, is also approved for a variety of medical indications, including migraine. Report
> Medco Health Solutions, an Express Scripts ($ESRX) subsidiary, said it would pay $7.9 million to settle allegations that it engaged in a kickback scheme with AstraZeneca ($AZN). Report
> Novartis ($NVS) said its cancer drug Afinitor helped delay cancer growth in patients with advanced neuroendocrine tumors. Report
> Pulmonary embolism patients aren't properly screened for the pulmonary hypertension that might follow, a Bayer study found. Report
> Hospitals urged Congress not to change a drug discount program that's designed to help facilities that serve a large proportion of needy patients. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: MD Anderson Cancer Center partners to start breast cancer pilot project using Apple Watch. Report | Follow @FierceMedDev
@VarunSaxena2: St. Jude says alternative imaging system is optimal during stenting procedures. Story | Follow @VarunSaxena2
@EmilyWFierce: San Francisco startup reels in $30M for disease outbreak prediction tech. More | Follow @EmilyWFierce
> Philips collaborates with Dutch hospital to develop diabetic foot disease Dx. More
> Issue that led to halt of St. Jude TAVR trial no cause for concern, EuroPCR experts say. News
Biotech News
@FierceBiotech: Regeneron's arthritis drug aces Phase III with the FDA in sight. News | Follow @FierceBiotech
@JohnCFierce: What's your list of top 5 public biotechs? (Potential, management, smart execution) I'd put $BLUE in that group. Any other suggestions? | Follow @JohnCFierce
> Pfizer vet Gutiérrez-Ramos takes the reins at Synlogic. Article
> Bluebird offers a promising peek at a potential cure for sickle cell. More
Vaccines News
> Canadian biotech Medicago building $200M vaccine plant. Item
> Genocea's genital herpes vaccine succeeds in Ph II. More
> Takeda, Daiichi Sankyo ink flu vaccine distribution pacts with Japan's Kaketsuken. Story
> Zydus Cadila preps for big splash into India's vaccines market. Article
> U.K.'s PsiOxus scores $39M for colorectal cancer vaccine combo trial. Report
CRO News
> Quintiles' founders bank $770M in secondary offering. Item
> InVentiv invests in compliance as regulations shift for real-world studies. Story
> Quotient Clinical soars in its first year after a PE buyout. Report
> WuXi posts another big quarter as it faces a big decision. Article
Pharma Manufacturing News
> Hospira recalls solution marked as heparin. Item
> Zydus Cadila said to be buying Claris' sterile injectables biz as landscape morphs. Story
> Apotex recalling generic Zyprexa because the antipsychotic may be too weak. News
> Fund grows to $200M for victims of meningitis outbreak tied to compounder. Article
> Medicago building $200M plant to manufacture vaccines from plants. Report
Pharma Asia News
> Sinocare said to bid $1B for Bayer diabetes devices, piping Panasonic. More
> China academy plans clinical trials on artemisinin derivative aimed at lupus. News
> Japan eyes higher target for generics despite missing earlier aims. Article
> Gilead's Sovaldi faces renewed advocacy CL pressure, this time for China and Russia. Story
> Glenmark gets India nod on shares sales to foreign investors, Temasek in. Report
And Finally... CareFirst BlueCross BlueShield said a cyberattack compromised the data of 1.1 million current and former members. Report